Preclinical screening of anticancer drugs using infrared (IR) microspectroscopy.
High-throughput label-free technologies such as IR microscopy can objectively assess the effect of drugs upon cellular systems, offering the potential of a valuable preclinical tool that can aid in the drug development process.